hereditary cancer
Foundation Medicine, Fulgent Genetics Partner to Launch Germline Testing in US
The Foundation Medicine next-generation sequencing-based panels use Fulgent's technology platform and will analyze genes associated with hereditary cancers.
BRCA1/2 Mutations Aren't Equal: Researchers Push for Reduced Penetrance Pathogenic Variant Category
Premium
Researchers worked with two labs to identify 16 consensus lower-risk pathogenic variants and are pushing for greater recognition of such variants.
NCCN Adds Prostate Cancer to Genetic Risk Assessment Guidelines
The NCCN also recently updated genetic risk guidelines for colorectal, endometrial, and gastric cancers.
Fulgent Genetics Wins VA Testing Contract Worth up to $99M
The agreement provides for up to $99 million for tests performed over a five-year period, ensuring access among the VA population.
Myriad Genetics, Flatiron Health Partner on EMR Integration of MyRisk Hereditary Cancer Test
The deal will allow doctors using Flatiron's cloud-based OncoEMR electronic medical record system to order Myriad's comprehensive cancer predisposition test.
May 31, 2023
Dec 5, 2022
Nov 1, 2022